The history should focus on developmental stages such as puberty and growth spurts, as well as androgen-dependent events such as early morning erections, frequency and intensity of sexual thoughts, and frequency of masturbation or intercourse. The physical examination should focus on secondary sex characteristics such as hair growth on the face, axilla, chest, and pubic regions; gynecomastia; testicular volume; prostate; and height and body proportions. Eunuchoidal proportions are defined as an arm span >2 cm greater than height and suggest that androgen deficiency occurred prior to epiphyseal fusion. Normal testicular size ranges from 3.5 to 5.5 cm in length, which corresponds to a volume of 12-25 mL. The presence of varicocele should be sought by palpation of the testicular veins with the pt standing. Pts with Klinefelter's syndrome have small (1-2 mL), firm testes.
A morning total testosterone level <10.4 nmol/L (<300 ng/dL), in association with symptoms, suggests testosterone deficiency. A level of >12.1 nmol/L (>350 ng/dL) makes the diagnosis of androgen deficiency unlikely. In men with testosterone levels between 6.9 and 12.1 nmol/L (200 and 350 ng/dL), the total testosterone level should be repeated and a free testosterone level should be measured by a reliable method. In older men and in pts with other clinical states that are associated with alterations in sex hormone-binding globulin levels, a direct measurement of free testosterone by equilibrium dialysis can be useful to confirm testosterone deficiency. When androgen deficiency has been found, LH should be measured to classify the pt as having primary (high LH) or secondary (low or inappropriately normal LH) hypogonadism. In men with primary hypogonadism of unknown cause, a karyotype should be performed to exclude Klinefelter's syndrome. Measurement of a prolactin level and MRI of the hypothalamic-pituitary region should be considered in men with secondary hypogonadism. Gynecomastia in the absence of androgen deficiency should be further evaluated (Fig. 174-1).
Treatment: Androgen Deficiency Treatment of hypogonadal men with androgens restores normal male secondary sexual characteristics (beard, body hair, external genitalia), male sexual drive, and masculine somatic development (hemoglobin, muscle mass), but not fertility. Administration of gradually increasing doses of testosterone is recommended for disorders in which hypogonadism occurred prior to puberty. Testosterone levels in the normal range may be achieved through daily application of transdermal testosterone patches (5-10 mg/d) or gel (50-100 mg/d), parenteral administration of a long-acting testosterone ester (e.g., 100-200 mg testosterone enanthate at 1- to 3-week intervals) or buccal testosterone tablets (30 mg/d). Hct should be monitored initially during testosterone therapy and the dose lowered if Hct is >54%. Prostate cancer, severe symptoms of lower urinary tract obstruction, baseline Hct >50%, severe sleep apnea, and class IV congestive heart failure are contraindications for androgen replacement. Gonadotropin therapy for secondary hypogonadism should be reserved for fertility induction. |
Section 13. Endocrinology and Metabolism